Literature DB >> 622971

Sequence of cardiac changes in Duchenne muscular dystrophy.

S B Heymsfield, T McNish, J V Perkins, J M Felner.   

Abstract

Boys with Duchenne muscular dystrophy (DMD) rarely have clinical evidence of myocardial dysfunction during life. Nevertheless, congestive heart failure is a frequent terminal event and autopsy invariably shows dystrophic myocardial involvement. Little is known regarding the progression of heart functional abnormalities in boys with DMD from birth to death. Therefore we have examined the hearts of 18 DMD boys aged 4 to 15 years with the following non-invasive methods: cardiovascular physical examination, electrocardiography, chest x-ray, serum enzymes, and echocardiography. Control subjects were 25 normal boys matched to their DMD counterparts by age and by body surface area. The dystrophic patients were divided into early (N = 9) and late (N = 9) DMD according to manual muscle testing of skeletal muscles. In early DMD, six of 23 cardiac indices differed from control boys; in the late stage, an additional five indices became abnormal. Early DMD was characterized by these abnormalities: tachycardia, large ECG R/S ratio in V1, augmented q wave voltages in Leads I, II, and V5 of the ECG, diminished contractile excursion of the left venticular posterior wall (LVPW) and interventricular septum, and decreased rate of relaxation of the LVPW. In late DMD additional cardiac abnormalities appeared: enlarged heart volume by x-ray, reduced cardiac ejection fraction, diminished change in left ventricular diameter from diastole to systole, reduced maximal systolic endocardial velocity, and decreased rate of circumferential fiber shortening as detected in the echocardiogram. Most of the cardiac abnormalities were revealed only by echocardiography, which is thus shown to be a sensitive method for monitoring the progression of cardiac dystrophy during the life span of the DMD child.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 622971     DOI: 10.1016/0002-8703(78)90358-7

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  18 in total

1.  Autonomic dysfunction: a driving force for myocardial fibrosis in young Duchenne muscular dystrophy patients?

Authors:  Tamara O Thomas; John L Jefferies; Angela Lorts; Jeffrey B Anderson; Zhiqian Gao; D Woodrow Benson; Kan N Hor; Linda H Cripe; Elaine M Urbina
Journal:  Pediatr Cardiol       Date:  2014-11-16       Impact factor: 1.655

2.  Steroid therapy and cardiac function in Duchenne muscular dystrophy.

Authors:  L W Markham; R L Spicer; P R Khoury; B L Wong; K D Mathews; L H Cripe
Journal:  Pediatr Cardiol       Date:  2005 Nov-Dec       Impact factor: 1.655

Review 3.  Cardiac assessment in duchenne and becker muscular dystrophies.

Authors:  Anitra Romfh; Elizabeth M McNally
Journal:  Curr Heart Fail Rep       Date:  2010-12

4.  Screening for cardiomyopathy in muscular dystrophy with tissue doppler imaging.

Authors:  Rachna Seth; Sandeep Seth; Veena Kalra
Journal:  Indian J Pediatr       Date:  2010-04-17       Impact factor: 1.967

5.  Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice.

Authors:  Brian Bostick; Yongping Yue; Yi Lai; Chun Long; Dejia Li; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2008-08       Impact factor: 5.695

6.  Cardiomyopathy of Duchenne muscular dystrophy.

Authors:  L D'Orsogna; J P O'Shea; G Miller
Journal:  Pediatr Cardiol       Date:  1988       Impact factor: 1.655

7.  DMD mutation and LTBP4 haplotype do not predict onset of left ventricular dysfunction in Duchenne muscular dystrophy.

Authors:  Charlotte S Van Dorn; Michael D Puchalski; Hsin-Yi Weng; Steven B Bleyl; Russell J Butterfield; Richard V Williams
Journal:  Cardiol Young       Date:  2018-05-16       Impact factor: 1.093

8.  Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy?

Authors:  Michael D Puchalski; Richard V Williams; Bojana Askovich; C Todd Sower; Kan H Hor; Jason T Su; Nathan Pack; Edward Dibella; William M Gottliebson
Journal:  Int J Cardiovasc Imaging       Date:  2008-08-07       Impact factor: 2.357

9.  Contractile activation and the effects of 2,3-butanedione monoxime (BDM) in skinned cardiac preparations from normal and dystrophic mice (129/ReJ).

Authors:  J M West; D G Stephenson
Journal:  Pflugers Arch       Date:  1989-03       Impact factor: 3.657

10.  The pattern of urinary catecholamines and their metabolites in Duchenne myopathy, in relation to disease evolution.

Authors:  Y Dalmaz; L Peyrin; J C Mamelle; D Tuil; R Gilly; J F Cier
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.